SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-039319
Filing Date
2017-06-12
Accepted
2017-06-12 20:30:56
Documents
1
Period of Report
2017-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4393
  Complete submission text file 0001209191-17-039319.txt   5999
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O 99 HAYDEN AVE 1 LEDGEMONT CENTER LEXINGTON MA 02173
Business Address
SANDAGE BOBBY W. JR., PHD. (Reporting) CIK: 0001046352 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21990 | Film No.: 17907802